Advance Care Planning
Recent research identified factors that increased the likelihood that clinicians would choose hospice care for themselves and examines how their preferences relate to the timing of end-of-life care discussions with patients.
Improved understanding of how to integrate the results into the treatment planning process is changing the course of treatment for some patients.
Cancer care entails a confusing labyrinth of screenings, tests, and treatments. This emerging role for nurses is becoming increasingly vital to achieve ideal patient outcomes.
Family-centered advance care planning left adolescent oncology patients significantly better informed than those who didn't have such sessions.
Early end-of-life talks are associated with less aggressive care and greater use of hospice services when patients do reach their final days.
Many persons who receive chemotherapy for incurable cancers may not understand that the treatment is unlikely to be curative.
A nurse-led palliative care intervention for persons newly diagnosed with metastatic cancer improved patients' emotional and mental quality of life.
The patient's daughter had been through the discharge process before. But she struggled with accepting her recurrent feelings. The nurse did, too.
Disease-specific advance care planning provides greater clarity about preferences, improving end-of-life care.
Prognosis is not good, but many patients still seek treatment, equating prolonged neurologic function with better quality of life.
Disease-specific advance care planning: Conversations emphasize patient preferences and provide claritySeptember 01, 2010
When planning for end-of-life care, disease-specific advance care planning delivers greater patient satisfaction and clarity about preferences.
Advance care planning can be applied in CPR decision-making at the end of life, but because medical technology advances mean increased length of palliative care and chronic illnesses, the decision of when to intervene has become more complex
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|